Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing Read more
New Handheld X-Ray Fluorescence Analyzer for Pharmaceutical Manufacturers Identifies Ionic Salt Raw Material in Seconds Read more
FDA Approves XARELTO (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients Read more
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis Read more